Pharma Companies Spend 19x more on Marketing than Research, and Returns are Dropping

Share it with your friends Like

Thanks! Share it with your friends!

Close

By Christina Sarich

The pharmaceutical industry swears the high cost of drugs is due to research and development costs, conveniently omitting the actual amount of money spent on the marketing of these drugs, which is exorbitantly more. A recent Deloitte report suggests that pharmaceutical companies are taking a hit because investments made in R&D on new drugs simply are not paying off anymore. [1]

As we previously reported, pharmaceutical companies spend more money on marketing drugs than research and development. Johnson & Johnson for example recently spent $17.5 billion on marketing and only $8.2 billion on research and development. Similarly Pfizer spent $11.4 …read more

Read more here: naturalsociety.com

    

  • Rating:
  • Views:308 views
  • Categories: Health